Atlas Trials

Observation Study: Superselective Drug-Eluting Chemoembolization in Unresectable Intermediate and Advanced HCC Patients

Clinical trial NCT03273608 · UNKNOWN

Trial details

NCT number
NCT03273608
Sponsor
Taipei Veterans General Hospital, Taiwan
Status
UNKNOWN
Study type
OBSERVATIONAL
Hepatocellular Carcinoma
Start date
2016-09-14
Primary completion
2019-09-30
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.